IL6R-STAT3-ADAR1 (P150) Interplay Promotes Oncogenicity in 1q21(amp) Multiple Myeloma

Haematologica - Italy
doi 10.3324/haematol.2019.221176
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Ferrata Storti Foundation (Haematologica)

Related search

Aberrant Hyperediting of Myeloma Transcriptome by Adar1 Confers Oncogenicity and Is a Marker of Poor Prognosis

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

The Hydroxymethylome of Multiple Myeloma Identifies FAM72D as a 1q21 Marker Linked to Proliferation

Haematologica
Hematology
2019English

Icaritin Suppresses Multiple Myeloma, by Inhibiting IL-6/JAK2/STAT3

Oncotarget
Oncology
2015English

Docosahexaenoic Acid (DHA) Promotes Immunogenic Apoptosis in Human Multiple Myeloma Cells, Induces Autophagy and Inhibits STAT3 in Both Tumor and Dendritic Cells

Genes and Cancer
Cancer ResearchGenetics
2017English

CD38-driven Mitochondrial Trafficking Promotes Bioenergetic Plasticity in Multiple Myeloma

Cancer Research
Cancer ResearchOncology
2019English

Concomitant Gain of 1q21 and MYC Translocation Define a Poor Prognostic Subgroup of Hyperdiploid Multiple Myeloma

Haematologica
Hematology
2015English

Regulation of STAT3 and NF-κB Activations by S-Nitrosylation in Multiple Myeloma

Free Radical Biology and Medicine
BiochemistryPhysiology
2017English

Cyclic AMP Induces Apoptosis in Multiple Myeloma Cells and Inhibits Tumor Development in a Mouse Myeloma Model

BMC Cancer
Cancer ResearchOncologyGenetics
2011English

Role of Tumor Suppressor P53 and Micro-Rna Interplay in Multiple Myeloma Pathogenesis

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy